A lack of race and ethnicity data in the treatment of hereditary hemorrhagic telangiectasia: a systematic review of intravenous bevacizumab efficacy

被引：0

作者：

Panagis Galiatsatos

Cheri Wilson

Jaime O’Brien

Anna J. Gong

Dylan Angiolillo

James Johnson

Carlie Myers

Sara Strout

Stephen Mathai

Gina Robinson

Nicholas R. Rowan

Clifford R. Weiss

机构：

[1] Johns Hopkins School of Medicine,Division of Pulmonary and Critical Care Medicine

[2] The Center of Clinical Excellence for Hereditary Hemorrhagic Telangiectasias at the Johns Hopkins Hospital,Medicine for the Greater Good

[3] Office of Diversity,Division of Anesthesiology and Critical Care Medicine

[4] Inclusion,Albert Gnaegi Center for Health Care Ethics

[5] and Health Equity,Department of Pharmacy

[6] Johns Hopkins School of Medicine,undefined

[7] Johns Hopkins School of Medicine,undefined

[8] Saint Louis University,undefined

[9] Johns Hopkins Hospital,undefined

来源：

Orphanet Journal of Rare Diseases | / 17卷

关键词：

Hereditary hemorrhagic telangiectasia; Bevacizumab; Race; Health equity;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 110 条

[31] Figueroa-Bodine J(2016)Racial disparities in melanoma survival J Am Acad Dermatol 75 undefined-undefined
[32] Livada N(2016)Skin cancer concerns in people of color: risk factors and prevention Asian Pac J Cancer Prev 17 undefined-undefined
[33] Richer SL(2005)Conceptualizing and categorizing race and ethnicity in health services research Health Serv Res 40 undefined-undefined
[34] Iyer VN(undefined)undefined undefined undefined undefined-undefined
[35] Apala DR(undefined)undefined undefined undefined undefined-undefined
[36] Pannu BS(undefined)undefined undefined undefined undefined-undefined
[37] Epperla N(undefined)undefined undefined undefined undefined-undefined
[38] Kapke JT(undefined)undefined undefined undefined undefined-undefined
[39] Karafin M(undefined)undefined undefined undefined undefined-undefined
[40] Friedman KD(undefined)undefined undefined undefined undefined-undefined